Medical News Today: Oncology News

Feeding infants with breast milk has been shown to improve baby health and even IQ. But according to dietitians, many new mums are unaware that breastfeeding also lowers their own risk of cancer and heart disease - two of the biggest killers among Australian women...

Tiny particles of iron oxide could become tools for simultaneous tumor imaging and treatment, because of their magnetic properties and toxic effects against brain cancer cells. In mice, researchers from Emory University School of Medicine have demonstrated how these particles can deliver antibodies to implanted brain tumors, while enhancing tumor visibility via magnetic resonance imaging (MRI)...

The Australian Greens' health plan would reduce the burden of cancers linked with obesity, smoking and alcohol in Australia, Cancer Council Australia said today...

New research in the FASEB Journal shows that a peptide derived from bee venom can deliver liposomes bearing drugs or diagnostic dyes to specific cells or tissues The next time you are stung by a bee, here's some consolation: a toxic protein in bee venom, when altered, significantly improves the effectiveness liposome-encapsulated drugs or dyes, such as those already used to ...

The Louisiana Tumor Registry (LTR) at the LSU Health Sciences Center New Orleans School of Public Health has been awarded a $12 million contract over seven years by the National Cancer Institute to continue its work as a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer registry. There are 18 competitively awarded SEER cancer registries in the United States...

The Virginia Tech Colleges of Engineering, Science, and Agriculture and Life Sciences have been awarded a $3 million, five-year grant from the National Science Foundation (NSF) to launch a Ph.D. training program aimed at preparing future researchers to solve emerging challenges at the intersection of the engineering and biological sciences...

There are several challenges to be overcome if therapeutic anticancer vaccines, which are designed to boost the patient's anticancer immune response, are to be successfully developed. For example, the viruses used to deliver the tumor protein to the patient's immune system are themselves targeted by the patient's immune system, inducing neutralizing and suppressive responses...

A new study suggests that consuming specific compounds in meat related to processing methods may be associated with an increased risk of developing bladder cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may be relevant for understanding the role of dietary exposures in cancer risk...

A new analysis from Canada has found that cancer patients from poorer communities have a greater chance of dying prematurely than individuals from more affluent backgrounds even though cancer stage at time of diagnosis is similar across socioeconomic groups...

Researchers at the Stanford University School of Medicine have challenged decades of accepted wisdom about bone marrow transplantation with a new study showing that mice receiving purified blood stem cells are less prone to complications than mice receiving stem cells plus purified T cells. The study, led by Judith Shizuru, MD, PhD, associate professor of medicine, was published online Aug...

GPC3 is a member of the glypican family of glycosylphosphatidylinositol-anchored cell-surface heparan sulfate proteoglycans. GPC3 is highly expressed in HCC cells and tissues. It is thought that GPC3 joins a multiprotein complex, which is composed of the ligand, receptor, GPC3, and probably other proteins...

A genome-wide study on Japanese subjects has identified 5 new genetic variations linked to prostate cancer and revealed differences and similarities between Europeans and Asians in susceptibility to the disease. Reported in Nature Genetics, the findings offer a first-ever glimpse of the genetic basis for prostate cancer susceptibility in a non-European population...

UroToday.com - Using modern platinum based chemotherapy, testicular cancer is a highly curable malignancy. The majority of men are diagnosed and treated in their second and third decades, and therefore persisting morbidity arising as a direct consequence of their treatment is of great concern...

Pancreatic cancers use the sugar fructose, very common in the Western diet, to activate a key cellular pathway that drives cell division, helping the cancer to grow more quickly, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has found...

UroToday.com - In the past several years, germline mutations in small sections of DNA, referred to as single nucleotide polymorphisms (SNPs) have been shown to correlate with the risk of developing prostate cancer (CaP). In fact, in a Scandinavian population, a combination of SNPs in a man with a positive family history of prostate cancer increased his risk for the disease 9-fold...

UroToday.com - In the online edition of the British Journal of Urology International, a group of investigators report on the selection of initial management for low-risk prostate cancer (CaP) in a contemporary cohort of patients in the UK. The database for the analysis was the British Association of Urological Surgeons Cancer Registry...

UroToday.com - Pathologic variables following radical prostatectomy (RP) for prostate cancer (CaP) that might suggest benefit from adjuvant radiotherapy include a positive surgical margin (PSM), seminal vesicle invasion (pT3B disease), and extracapsular extension (pT3a disease)...

UroToday.com - "Is LESS, more"? The question certainly needs to be answered given all of the interest and expense that laparoendoscopic single site (LESS) surgery has incurred...

UroToday.com - In Urologia Internationalis, a group headed by Dr. Arnulf Stenzl report on the use of the prostate cancer gene 3 (PCA3) test in their clinical practice in Tübingen, Germany. PCA3 detects the untranscribed mRNA of the gene, which does not encode for a protein. PCA3 is expressed almost exclusively in prostate tissue...

UroToday.com - Dr. Michael Zelefsky and colleagues from the Department of Radiation Oncology at Memorial Sloan-Kettering Cancer Center report in Urology on the feasibility of using CT during prostate brachytherapy for prostate cancer (CaP) to evaluate intraoperative dosimetry and for correction of deficient dose regions...